1. Antiproliferative Activity and VEGF Expression Reduction in MCF7 and PC-3 Cancer Cells by Paclitaxel and Imatinib Co-encapsulation in Folate-Targeted Liposomes
   Marco Júnio Peres-Filho et al, 2018, AAPS PharmSciTech CrossRef
2. Current World Literature
   , 2012, Current Opinion in Nephrology & Hypertension CrossRef
3. Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response
   Sara Zafarnia et al, 2017, Neoplasia CrossRef
4. Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro
   CLAUDIA UMBREIT et al, 2014, Oncology Reports CrossRef
5. Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor
   Hye Min Kim et al, 2016, Disease Markers CrossRef
6. PDGF: the nuts and bolts of signalling toolbox
   Ammad Ahmad Farooqi et al, 2011, Tumor Biology CrossRef
7. Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer
   Johannes Doescher et al, 2019, Immunotherapy CrossRef
8. Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model
   Cristina Maria de Souza et al, 2014, Biomedicine & Pharmacotherapy CrossRef
9. Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment
   Robert Kleszcz, 2023, Cancers CrossRef